Author Topic: (Abst.) Safety and efficacy of autologous HSCT for MS in Norway  (Read 15 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8568
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Safety and efficacy of autologous HSCT for MS in Norway
« on: December 14, 2019, 04:59:16 pm »
This is a small study (30 patients) but the finding that some patients had amenorrhea lasting more than 12 months and ovarian failure would be a concern.


From PubMed (December 14, 2019), "Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway":


https://www.ncbi.nlm.nih.gov/pubmed/31833798
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
59 Views
Last post May 31, 2016, 01:48:51 pm
by agate
1 Replies
70 Views
Last post October 29, 2016, 06:34:51 am
by agate
0 Replies
70 Views
Last post February 20, 2017, 10:12:37 am
by agate
2 Replies
87 Views
Last post September 08, 2019, 04:17:59 pm
by agate
0 Replies
54 Views
Last post September 30, 2018, 07:31:15 pm
by agate